CT
Celldex Therapeutics Inc
🇩🇪XFRA.TCE2GermanyHealthcare
€33.48EURup +2.08 (+6.62%)After-hoursEnd of day8:09 PM
Price€33.48+2.08 (+6.62%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US15117B2025
- CUSIP
- Not reported
Company
- Employees
- 198
- Headquarters
- Hampton, United States
- Website
- https://www.celldex.com
- CEO
- Mr. Anthony S. Marucci M.B.A.
Market
- Shares outstanding
- 66.4M
- Market cap
- €2.22B
Highlights
No high and low reported for today's session.
- Market cap
- €2.22B
- EPS LTM
- -$3.86
- P/E LTM
- -9.64
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $112K-98.07%down year on year
- Net income
- -$300.59M-50.59%down year on year
- Gross margin
- -56,850.89%-2,138.08%down year on year
- Free cash flow
- -$241.82M-29.09%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.